Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,349.10 -5.26 -0.03%
S&P 500 1,666.36 -1.11 -0.07%
Nasdaq 3,498.52 -0.44 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,824.50 +6.51 0.23%
FTSE 100 6,755.63 +32.57 0.48%
DAX 8,455.83 +57.83 0.69%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Eli Lilly & Co

+ Add to Watchlist

LLY:US

55.0700 USD 0.8300 1.48%

As of 15:02:13 ET on 05/20/2013.

Company Profile for Eli Lilly & Co (LLY)

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company's products are sold in countries around the world. Eli Lilly's products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.

Contact Information

Eli Lilly & Co

Lilly Corporate Center
Indianapolis, IN 46285
United States
Phone: 1-317-276-2000
Fax: 1-317-276-3492

Key Executives for Eli Lilly & Co (LLY)

John C LechleiterChairman/President/CEOShaun HawkinsChief Diversity Officer
Maria A CrowePres:Manufacturing OperationsDerica W RiceExec VP:Global Svcs/CFO/Acting CEO
Jan M LundbergExec VP:Science/Pres:ResearchEnrique A ConternoSenior VP/Pres:Diabetes
Susan Mahony "Sue"Senior VP/Pres:OncologyDavid A Ricks "Dave"Senior VP/Pres:BIO-Medicines
Jeffrey N Simmons "Jeff"Senio VP/Pres:Elanco AnimalJacques TapieroSenior VP/Pres:Emerging Markets
Michael J HarringtonSenior VP/General CounselMelissa S BarnesSenior VP:Enterprise Risk Mgmt
Barton R Peterson "Bart"Senior VP:Corporate AffairsFionnuala M WalshSenior VP:Global Quality
Stephen F FrySenior VP:Human ResourcesPhilip Johnson "Phil"VP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil